Genprex Inc (GNPX)
2.21
+0.09
(+4.25%)
USD |
NASDAQ |
Apr 26, 16:00
2.10
-0.11
(-4.98%)
After-Hours: 20:00
Genprex 1 Year Total Returns (Daily): -93.09% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | -93.09% |
April 25, 2024 | -93.52% |
April 24, 2024 | -93.81% |
April 23, 2024 | -94.60% |
April 22, 2024 | -94.95% |
April 19, 2024 | -94.62% |
April 18, 2024 | -94.16% |
April 17, 2024 | -94.00% |
April 16, 2024 | -93.10% |
April 15, 2024 | -92.95% |
April 12, 2024 | -91.75% |
April 11, 2024 | -91.49% |
April 10, 2024 | -91.20% |
April 09, 2024 | -90.75% |
April 08, 2024 | -91.08% |
April 05, 2024 | -90.62% |
April 04, 2024 | -91.10% |
April 03, 2024 | -91.16% |
April 02, 2024 | -92.20% |
April 01, 2024 | -91.84% |
March 28, 2024 | -91.99% |
March 27, 2024 | -92.78% |
March 26, 2024 | -92.39% |
March 25, 2024 | -91.67% |
March 22, 2024 | -90.56% |
Date | Value |
---|---|
March 21, 2024 | -90.43% |
March 20, 2024 | -90.16% |
March 19, 2024 | -89.09% |
March 18, 2024 | -86.80% |
March 15, 2024 | -87.79% |
March 14, 2024 | -87.83% |
March 13, 2024 | -88.55% |
March 12, 2024 | -88.31% |
March 11, 2024 | -86.95% |
March 08, 2024 | -90.12% |
March 07, 2024 | -89.98% |
March 06, 2024 | -90.14% |
March 05, 2024 | -90.96% |
March 04, 2024 | -90.70% |
March 01, 2024 | -90.18% |
February 29, 2024 | -91.60% |
February 28, 2024 | -91.86% |
February 27, 2024 | -90.95% |
February 26, 2024 | -91.89% |
February 23, 2024 | -92.16% |
February 22, 2024 | -93.29% |
February 21, 2024 | -93.32% |
February 20, 2024 | -93.73% |
February 16, 2024 | -93.33% |
February 15, 2024 | -93.11% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.95%
Minimum
Apr 22 2024
2.01K%
Maximum
Dec 23 2020
41.70%
Average
-44.77%
Median
Jul 12 2023
1 Year Total Returns (Daily) Benchmarks
Jaguar Health Inc | -67.27% |
FibroGen Inc | -93.62% |
BioXcel Therapeutics Inc | -87.45% |
TFF Pharmaceuticals Inc | -79.68% |
4D Molecular Therapeutics Inc | 13.03% |